Ramesh Kumar Sistla

This inventor holds 32 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 18 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited, Merck Patent Gmbh. Active years: 2013-2026.

USPTO Granted Patents = 32 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 18 (Patent Applications = 18)

Average Co-Inventor Count = 10.7

ph-index = 6

Forward Citations = 86(Granted Patents)

Company Filing History:

33 out of 3,735

Bristol-Myers Squibb Compnay

patents

2 out of 7

Syngene International Limited

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

PAD4 Inhibitors

IRAK4 Inhibitors

Indoleamine 2,3-Dioxygenase

Kinase Modulators

Biaryl Kinase Inhibitors

Farnesoid X Receptor Modulators

Thiazolyl Compounds

Pyridyl Compounds

Bicyclic Compounds

Triazolo Compounds

Aminopyridine Compounds

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673042 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2026-07-07),

2. 12473304 - Heterocyclic PAD4 inhibitors (2025-11-18),

3. 12286428 - Tricyclic heteroaryl compounds useful as IRAK4 inhibitors (2025-04-29),

4. 12059420 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2024-08-13),

5. RE49893 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2024-04-02),

6. RE49880 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2024-03-26),

7. 11739098 - Substituted indole compounds (2023-08-29),

8. 11672780 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2023-06-13),

9. 10959986 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2021-03-30),

10. 10912766 - [1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds (2021-02-09),

11. 10730863 - Bridged bicyclic compounds as farnesoid X receptor modulators (2020-08-04),

12. 10660877 - Pyridyl substituted indole compounds (2020-05-26),

13. 10618903 - Heteroaryl substituted aminopyridine compounds (2020-04-14),

14. 10544133 - Heteroaryl substituted pyridyl compounds useful as kinase modulators (2020-01-28),

15. 10544120 - Biaryl kinase inhibitors (2020-01-28),

Title: Ramesh Kumar Sistla - Innovator from Bengaluru

Introduction: Ramesh Kumar Sistla is a renowned inventor hailing from Bengaluru, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ramesh Kumar Sistla holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ramesh Kumar Sistla has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Ramesh Kumar Sistla has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Ramesh Kumar Sistla's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists worldwide.